Medical Total Liab vs Long Term Debt Analysis

MPW Stock

USD 4.51 0.05 1.10%

Medical Properties financial indicator trend analysis is infinitely more than just investigating Medical Properties Trust recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Medical Properties Trust is a good investment. Please check the relationship between Medical Properties Total Liab and its Long Term Debt accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medical Properties Trust. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.

Total Liab vs Long Term Debt

Total Liab vs Long Term Debt Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Medical Properties Trust Total Liab account and Long Term Debt. At this time, the significance of the direction appears to have totally related.

The correlation between Medical Properties' Total Liab and Long Term Debt is 0.99. Overlapping area represents the amount of variation of Total Liab that can explain the historical movement of Long Term Debt in the same time period over historical financial statements of Medical Properties Trust, assuming nothing else is changed. The correlation between historical values of Medical Properties' Total Liab and Long Term Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Liab of Medical Properties Trust are associated (or correlated) with its Long Term Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Long Term Debt has no effect on the direction of Total Liab i.e., Medical Properties' Total Liab and Long Term Debt go up and down completely randomly.

Correlation Coefficient

0.99

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Long Term Debt

Long-term debt is a debt that Medical Properties Trust has held for over one year. Long-term debt appears on Medical Properties Trust balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Medical Properties Trust balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.

Most indicators from Medical Properties' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Medical Properties Trust current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medical Properties Trust. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.

At this time, Medical Properties' Selling General Administrative is fairly stable compared to the past year. Enterprise Value is likely to climb to about 4.2 B in 2024, despite the fact that Discontinued Operations is likely to grow to (855.00).

	2021	2022	2023	2024 (projected)
Gross Profit	1.5B	1.5B	830.2M	537.8M
Total Revenue	1.5B	1.5B	871.8M	549.6M

Gross Profit Total Revenue

Medical Properties fundamental ratios Correlations

	Total Assets	Accounts Payable	Cash	Other Assets	Total Liab	Common Stock	Short Long Term Debt Total	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Net Debt	Retained Earnings	Non Current Assets Total	Non Currrent Assets Other	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Stockholder Equity	Property Plant And Equipment Gross	Total Current Assets	Other Current Liab	Total Current Liabilities	Current Deferred Revenue
Total Assets		0.63	0.43	0.66	1.0	0.98	1.0	0.99	0.66	0.35	0.99	-0.15	1.0	0.09	0.99	0.42	0.82	0.98	0.99	0.99	0.99	0.32	0.87	-0.16	0.71	0.37
Accounts Payable	0.63		0.15	0.49	0.62	0.56	0.63	0.64	0.47	0.39	0.63	0.1	0.63	-0.18	0.61	0.16	0.63	0.58	0.6	0.61	0.62	-0.05	0.6	-0.25	0.53	-0.02
Cash	0.43	0.15		0.1	0.38	0.48	0.37	0.5	0.19	-0.08	0.29	0.4	0.39	0.46	0.41	1.0	0.42	0.43	0.41	0.41	0.46	0.22	0.72	-0.02	0.03	0.23
Other Assets	0.66	0.49	0.1		0.68	0.66	0.66	0.63	0.48	-0.14	0.67	-0.59	0.67	0.09	0.61	0.09	0.35	0.73	0.69	0.61	0.68	0.11	0.47	0.43	0.86	0.18
Total Liab	1.0	0.62	0.38	0.68		0.97	1.0	0.98	0.68	0.34	0.99	-0.19	1.0	0.08	0.99	0.36	0.82	0.97	0.99	0.99	0.99	0.3	0.85	-0.16	0.73	0.36
Common Stock	0.98	0.56	0.48	0.66	0.97		0.97	0.99	0.61	0.3	0.96	-0.19	0.98	0.13	0.97	0.46	0.75	0.99	0.99	0.97	0.99	0.4	0.85	-0.07	0.71	0.46
Short Long Term Debt Total	1.0	0.63	0.37	0.66	1.0	0.97		0.98	0.66	0.39	1.0	-0.17	1.0	0.05	0.99	0.35	0.81	0.97	0.98	0.99	0.98	0.3	0.85	-0.18	0.72	0.35
Total Stockholder Equity	0.99	0.64	0.5	0.63	0.98	0.99	0.98		0.63	0.36	0.96	-0.08	0.99	0.1	0.98	0.49	0.81	0.98	0.98	0.98	0.99	0.31	0.89	-0.15	0.67	0.36
Other Liab	0.66	0.47	0.19	0.48	0.68	0.61	0.66	0.63		0.01	0.66	0.04	0.64	0.52	0.71	0.17	0.86	0.57	0.63	0.71	0.62	0.35	0.69	-0.49	0.24	0.34
Property Plant And Equipment Net	0.35	0.39	-0.08	-0.14	0.34	0.3	0.39	0.36	0.01		0.41	0.3	0.37	-0.71	0.37	-0.08	0.29	0.27	0.33	0.37	0.32	0.07	0.15	-0.42	0.08	0.07
Net Debt	0.99	0.63	0.29	0.67	0.99	0.96	1.0	0.96	0.66	0.41		-0.22	0.99	0.0	0.99	0.27	0.8	0.96	0.98	0.99	0.97	0.29	0.8	-0.18	0.74	0.35
Retained Earnings	-0.15	0.1	0.4	-0.59	-0.19	-0.19	-0.17	-0.08	0.04	0.3	-0.22		-0.18	0.12	-0.09	0.42	0.24	-0.28	-0.21	-0.1	-0.18	-0.17	0.18	-0.65	-0.69	-0.22
Non Current Assets Total	1.0	0.63	0.39	0.67	1.0	0.98	1.0	0.99	0.64	0.37	0.99	-0.18		0.05	0.99	0.37	0.79	0.98	0.99	0.99	0.99	0.31	0.84	-0.14	0.73	0.37
Non Currrent Assets Other	0.09	-0.18	0.46	0.09	0.08	0.13	0.05	0.1	0.52	-0.71	0.0	0.12	0.05		0.13	0.46	0.35	0.08	0.08	0.12	0.09	0.18	0.39	-0.15	-0.2	0.17
Long Term Debt	0.99	0.61	0.41	0.61	0.99	0.97	0.99	0.98	0.71	0.37	0.99	-0.09	0.99	0.13		0.4	0.86	0.95	0.97	1.0	0.98	0.32	0.88	-0.26	0.64	0.36
Cash And Short Term Investments	0.42	0.16	1.0	0.09	0.36	0.46	0.35	0.49	0.17	-0.08	0.27	0.42	0.37	0.46	0.4		0.41	0.42	0.39	0.4	0.44	0.16	0.72	-0.02	0.03	0.17
Net Receivables	0.82	0.63	0.42	0.35	0.82	0.75	0.81	0.81	0.86	0.29	0.8	0.24	0.79	0.35	0.86	0.41		0.7	0.75	0.86	0.77	0.25	0.9	-0.62	0.28	0.23
Common Stock Total Equity	0.98	0.58	0.43	0.73	0.97	0.99	0.97	0.98	0.57	0.27	0.96	-0.28	0.98	0.08	0.95	0.42	0.7		0.99	0.95	0.99	0.36	0.82	0.03	0.79	0.42
Common Stock Shares Outstanding	0.99	0.6	0.41	0.69	0.99	0.99	0.98	0.98	0.63	0.33	0.98	-0.21	0.99	0.08	0.97	0.39	0.75	0.99		0.97	0.99	0.37	0.83	-0.08	0.74	0.43
Non Current Liabilities Total	0.99	0.61	0.41	0.61	0.99	0.97	0.99	0.98	0.71	0.37	0.99	-0.1	0.99	0.12	1.0	0.4	0.86	0.95	0.97		0.98	0.31	0.88	-0.25	0.65	0.36
Other Stockholder Equity	0.99	0.62	0.46	0.68	0.99	0.99	0.98	0.99	0.62	0.32	0.97	-0.18	0.99	0.09	0.98	0.44	0.77	0.99	0.99	0.98		0.33	0.86	-0.08	0.73	0.39
Property Plant And Equipment Gross	0.32	-0.05	0.22	0.11	0.3	0.4	0.3	0.31	0.35	0.07	0.29	-0.17	0.31	0.18	0.32	0.16	0.25	0.36	0.37	0.31	0.33		0.24	-0.04	0.12	0.95
Total Current Assets	0.87	0.6	0.72	0.47	0.85	0.85	0.85	0.89	0.69	0.15	0.8	0.18	0.84	0.39	0.88	0.72	0.9	0.82	0.83	0.88	0.86	0.24		-0.31	0.43	0.26
Other Current Liab	-0.16	-0.25	-0.02	0.43	-0.16	-0.07	-0.18	-0.15	-0.49	-0.42	-0.18	-0.65	-0.14	-0.15	-0.26	-0.02	-0.62	0.03	-0.08	-0.25	-0.08	-0.04	-0.31		0.42	0.01
Total Current Liabilities	0.71	0.53	0.03	0.86	0.73	0.71	0.72	0.67	0.24	0.08	0.74	-0.69	0.73	-0.2	0.64	0.03	0.28	0.79	0.74	0.65	0.73	0.12	0.43	0.42		0.2
Current Deferred Revenue	0.37	-0.02	0.23	0.18	0.36	0.46	0.35	0.36	0.34	0.07	0.35	-0.22	0.37	0.17	0.36	0.17	0.23	0.42	0.43	0.36	0.39	0.95	0.26	0.01	0.2

Click cells to compare fundamentals

Medical Properties Account Relationship Matchups

Medical Properties fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	14.5B	16.8B	20.5B	19.7B	18.3B	19.2B
Accounts Payable	(107.9M)	387.5M	603.6M	621.3M	412.2M	432.8M
Cash	1.5B	549.9M	459.2M	235.7M	250.0M	258.7M
Other Assets	1.5B	15.0B	3.9B	632.6M	16.3B	17.2B
Total Liab	7.4B	9.5B	12.1B	11.1B	10.7B	11.2B
Common Stock	371K	518K	541K	597K	599K	629.0K
Short Long Term Debt Total	7.1B	9.0B	11.4B	11.3B	10.2B	10.7B
Total Stockholder Equity	7.0B	7.3B	8.4B	8.6B	7.6B	8.0B
Other Liab	45.7M	180.9M	183.6M	70.3M	80.9M	61.7M
Net Debt	5.7B	8.5B	11.0B	11.1B	9.9B	10.4B
Retained Earnings	83.0M	(71.4M)	(87.7M)	116.3M	(971.8M)	(923.2M)
Non Current Assets Total	12.1B	14.9B	17.9B	18.2B	16.9B	17.8B
Non Currrent Assets Other	10.5B	12.5B	15.3B	(12.4B)	109.0M	114.5M
Long Term Debt	7.0B	8.9B	11.3B	10.3B	8.5B	9.0B
Cash And Short Term Investments	1.5B	549.9M	459.2M	235.7M	250.0M	271.7M
Net Receivables	910.4M	1.4B	2.1B	1.2B	681.0M	424.2M
Common Stock Total Equity	371K	518K	541K	597K	686.6K	720.9K
Common Stock Shares Outstanding	428.3M	530.5M	590.1M	598.8M	598.5M	628.4M
Liabilities And Stockholders Equity	14.5B	16.8B	20.5B	19.7B	18.3B	19.2B
Non Current Liabilities Total	7.1B	9.0B	11.4B	10.4B	8.7B	9.1B
Other Stockholder Equity	7.0B	7.5B	8.6B	8.5B	8.6B	9.0B
Total Current Assets	2.4B	1.9B	2.6B	1.4B	1.4B	1.3B
Accumulated Other Comprehensive Income	(62.9M)	(51.3M)	(36.7M)	(59.2M)	42.5M	44.6M
Other Current Liab	291.5M	(114.1M)	(1.6B)	(929.6M)	1.1B	1.1B
Total Current Liabilities	307.6M	474.9M	633.4M	649.1M	2.0B	2.1B
Current Deferred Revenue	16.1M	36.2M	25.6M	27.7M	38.0M	36.1M
Other Current Assets	(1.8B)	(1.1B)	(1.2B)	304.5M	(931.1M)	(884.5M)
Short Term Debt	107.9M	165.4M	1.6B	929.6M	463.1M	569.5M
Intangible Assets	622.1M	1.3B	1.4B	1.4B	1.0B	983.1M
Inventory	1.8B	1.0	1.2B	(304.5M)	(43.0M)	(40.8M)
Net Tangible Assets	6.4B	6.0B	8.4B	7.2B	8.3B	4.3B
Noncontrolling Interest In Consolidated Entity	107K	5.3M	5.5M	1.6M	1.4M	1.3M
Retained Earnings Total Equity	83.0M	(71.4M)	(87.7M)	116.3M	104.7M	109.9M
Long Term Debt Total	7.0B	8.9B	11.3B	10.3B	11.8B	12.4B
Capital Surpluse	7.0B	7.5B	8.6B	8.5B	9.8B	5.1B

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Medical Properties Trust is a strong investment it is important to analyze Medical Properties' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Medical Properties' future performance. For an informed investment choice regarding Medical Stock, refer to the following important reports:

How To Invest In Medical

Details

Is Medical Stock a good investment?

Details

What is Medical Properties' Net Worth?

Details

Largest Diversified REITs Companies

View

Largest Equity Real Estate Investment Trusts (REITs) Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medical Properties Trust. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.

You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Complementary Tools for Medical Stock analysis

When running Medical Properties' price analysis, check to measure Medical Properties' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medical Properties is operating at the current time. Most of Medical Properties' value examination focuses on studying past and present price action to predict the probability of Medical Properties' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medical Properties' price. Additionally, you may evaluate how the addition of Medical Properties to your portfolios can decrease your overall portfolio volatility.

	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
	AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities
	Commodity Directory Find actively traded commodities issued by global exchanges
	Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities
	Risk-Return Analysis View associations between returns expected from investment and the risk you assume
	Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios
	Insider Screener Find insiders across different sectors to evaluate their impact on performance
	Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities
	Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency

Is Medical Properties' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medical Properties. If investors know Medical will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medical Properties listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.49)

Dividend Share

0.88

Earnings Share

(0.93)

Revenue Per Share

1.48

Quarterly Revenue Growth

(0.13)

The market value of Medical Properties Trust is measured differently than its book value, which is the value of Medical that is recorded on the company's balance sheet. Investors also form their own opinion of Medical Properties' value that differs from its market value or its book value, called intrinsic value, which is Medical Properties' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medical Properties' market value can be influenced by many factors that don't directly affect Medical Properties' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Medical Properties' value and its price as these two are different measures arrived at by different means. Investors typically determine if Medical Properties is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medical Properties' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Medical Total Liab vs Long Term Debt Analysis

Total Liab vs Long Term Debt

Total Liab vs Long Term Debt Correlation Analysis

Correlation Coefficient

Total Liab

Long Term Debt

Medical Properties fundamental ratios Correlations

Medical Properties Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Medical Properties fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Medical Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Liab	+ 1.0	Total Assets
Short Long Term Debt Total	+ 1.0	Total Assets
Non Current Assets Total	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Cash
Short Long Term Debt Total	+ 1.0	Total Liab
Non Current Assets Total	+ 1.0	Total Liab

Non Currrent Assets Other	- 0.71	Property Plant And Equipment Net
Total Current Liabilities	- 0.69	Retained Earnings
Other Current Liab	- 0.65	Retained Earnings
Other Current Liab	- 0.62	Net Receivables
Retained Earnings	- 0.59	Other Assets
Other Current Liab	- 0.49	Other Liab